State AG Pulse Season 2 available now

News & Insights

  • Clear

Congressional Efforts to Combat New Street Drug Threat Earn Bipartisan AG Support

A bipartisan coalition of 39 AGs sent a letter to Congressional leaders urging the swift passage of the Combatting Illicit Xylazine Act, which would provide resources to fight the recent uptick in overdoses and deaths caused by use of the street drug. Xylazine is manufactured for use as a non-opioid veterinary tranquilizer for large animals,…

Read More

CVS Settles with Massachusetts AG for $6.15 Million over Alleged Workers’ Compensation Pricing Violations

Massachusetts AG Andrea Campbell settled with CVS Pharmacy, Inc. to resolve allegations that the company billed payors of workers’ compensation claims for prescription drugs in excess of amounts permitted by Massachusetts workers’ compensation laws and regulations. According to the settlement, AG Campbell alleges that various CVS locations in the Commonwealth failed to follow prescription pricing…

Read More

AG James Secures Insulin Price Cap for New Yorkers from Nation’s Two Largest Manufacturers

New York AG Letitia James reached agreements with Eli Lilly and Company and Sanofi-Aventis U.S. LLC to resolve an investigation into insulin pricing practices which found that the list prices set by insulin manufacturers have increased dramatically over the past two decades, and make the product unaffordable to many insulin users.

Read More

CVS and Walgreens Receive Opposing AG Letters Regarding Plans to Offer Medication Abortion

A group of 23 Democratic AGs sent a letter to CVS Heath and Walgreens Boots Alliance, Inc., sharing their support for the companies’ recent announcements that they would become certified to sell mifepristone and misoprostol, drugs used in medication abortions, in their retail pharmacies. The announcements followed the FDA’s change to its regulations to allow…

Read More

Centene to Pay $215 Million to California over Medicaid Overbilling Allegations

California AG Rob Bonta settled with pharmacy benefit manager (PBM) Centene Corporation and its subsidiaries in connection with alleged overcharges by Centene to California’s Medi-Cal program. AG Bonta alleges that Centene overcharged the Medi-Cal system by reporting inflated prescription drug costs. In particular, he alleges that Centene leveraged its PBM contracts to save its managed…

Read More